1. Home
  2. RDY vs CDE Comparison

RDY vs CDE Comparison

Compare RDY & CDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
  • CDE
  • Stock Information
  • Founded
  • RDY 1984
  • CDE 1928
  • Country
  • RDY India
  • CDE United States
  • Employees
  • RDY N/A
  • CDE N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • CDE Precious Metals
  • Sector
  • RDY Health Care
  • CDE Basic Materials
  • Exchange
  • RDY Nasdaq
  • CDE Nasdaq
  • Market Cap
  • RDY 11.6B
  • CDE 12.6B
  • IPO Year
  • RDY N/A
  • CDE N/A
  • Fundamental
  • Price
  • RDY $14.86
  • CDE $19.11
  • Analyst Decision
  • RDY Strong Buy
  • CDE Strong Buy
  • Analyst Count
  • RDY 2
  • CDE 2
  • Target Price
  • RDY $16.95
  • CDE $12.00
  • AVG Volume (30 Days)
  • RDY 1.1M
  • CDE 15.6M
  • Earning Date
  • RDY 10-24-2025
  • CDE 10-29-2025
  • Dividend Yield
  • RDY 0.48%
  • CDE N/A
  • EPS Growth
  • RDY 2.20
  • CDE N/A
  • EPS
  • RDY 0.79
  • CDE 0.39
  • Revenue
  • RDY $3,897,394,052.00
  • CDE $1,459,632,000.00
  • Revenue This Year
  • RDY $7.33
  • CDE $86.24
  • Revenue Next Year
  • RDY $2.00
  • CDE $6.06
  • P/E Ratio
  • RDY $18.42
  • CDE $48.90
  • Revenue Growth
  • RDY 15.86
  • CDE 63.68
  • 52 Week Low
  • RDY $12.26
  • CDE $4.58
  • 52 Week High
  • RDY $16.17
  • CDE $23.62
  • Technical
  • Relative Strength Index (RSI)
  • RDY 63.75
  • CDE 51.11
  • Support Level
  • RDY $14.00
  • CDE $20.64
  • Resistance Level
  • RDY $14.48
  • CDE $23.62
  • Average True Range (ATR)
  • RDY 0.20
  • CDE 1.34
  • MACD
  • RDY 0.08
  • CDE -0.36
  • Stochastic Oscillator
  • RDY 91.02
  • CDE 26.39

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About CDE Coeur Mining Inc.

Coeur Mining Inc is a metals producer focused on mining precious minerals in the Americas. It is involved in the discovery and mining of gold and silver and generates the vast majority of revenue from the sale of these precious metals. The operating mines of the company are palmarejo, Rochester, Wharf, and Kensington. Its projects are located in the United States, Canada, and Mexico.

Share on Social Networks: